Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease

<p>Multiple myeloma is a fatal haematological malignancy, in which the majority of patients either present with or develop a destructive and debilitating osteolytic bone disease. The bone disease is characterised by an increase in osteoclastogenesis and by osteoblast suppression. Current trea...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखक: Leng, H
अन्य लेखक: Simon, K
स्वरूप: थीसिस
भाषा:English
प्रकाशित: 2019
विषय: